A Chinese drugmaker with close military ties is seeking fast-track approval for a drug that it says can cure Ebola as China joins the race to help treat a deadly outbreak of the disease, which has spread from Africa to the United States and Europe.
Sihuan Pharmaceutical Holdings Group Ltd. signed a tie-up with Chinese research Academy of Military Medical Sciences last week to help push the drug, called JK-05, through the approval process in China and bring it to market.
The drug, developed by the academy, is currently approved for emergency military use only.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.